About Invistics
Invistics is a company based in Norcross (United States) founded in 1999 was acquired by Wolters Kluwer in June 2023. Invistics has raised $7.5 million across 3 funding rounds from investors including Wolters Kluwer, Atlanta Technology Angels and Intersouth Partners. Invistics offers products and services including Sentri7 Drug Diversion, UpToDate, and CCH Axcess. Invistics operates in a competitive market with competitors including Syncron, DecisionPoint, Generix Group, HighJump and Logiwa, among others.
- Headquarter Norcross, United States
-
Sectors
Technology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Invistics Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.5 M (USD)
in 3 rounds
-
Latest Funding Round
$5 M (USD), Series B
Jan 28, 2005
-
Investors
Wolters Kluwer
& 4 more
-
Employee Count
Not available
-
Acquired by
Wolters Kluwer
(Jun 07, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Invistics
Invistics offers a comprehensive portfolio of products and services, including Sentri7 Drug Diversion, UpToDate, and CCH Axcess.
Software for detecting drug diversion and ensuring compliance in healthcare
Platform providing trusted medical information for clinical decision-making
Cloud-based tools for tax preparation and workflow management
People of Invistics
Unlock access to complete
Unlock access to complete
Funding Insights of Invistics
Invistics has successfully raised a total of $7.5M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in January 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Invistics
Invistics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Wolters Kluwer, Atlanta Technology Angels and Intersouth Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Locked | Locked | Locked | |
|
Angel investments are provided across Atlanta and Georgia.
|
Locked | Locked | Locked | |
|
Private equity capital is invested in small and mid-sized businesses.
|
Locked | Locked | Locked |
Investor details for Invistics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Invistics
Investment portfolio details for Invistics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Invistics
Detailed financials for Invistics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invistics Comparisons
Peer comparison for Invistics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Invistics
Invistics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syncron, DecisionPoint, Generix Group, HighJump and Logiwa, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of cloud-based inventory optimization software
|
|
| Locked | Locked | Locked |
Provider of a field service and warehouse management solution
|
|
| Locked | Locked | Locked |
Supply chain management and collaboration solutions are provided globally.
|
|
| Locked | Locked | Locked |
Cloud-based warehouse management software is supplied for logistics operations.
|
|
| Locked | Locked | Locked |
Cloud-based warehouse management systems are provided for e-commerce fulfillment.
|
Detailed competitors of Invistics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invistics
Complete news archive for Invistics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invistics
Invistics was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Invistics is headquartered in Norcross, United States. It is registered at Norcross, Georgia, United States.
Invistics is a funded company, having raised a total of $7.5M across 3 funding rounds to date.
Invistics was founded in 1999 in Norcross, United States, focusing on the supply chain and manufacturing sectors. Consulting services and software solutions are delivered to support supplier collaboration and optimize inventory levels through analytics and simulation. Manufacturing batch and lot optimization is facilitated, along with quote lead time calculations grounded in Six Sigma and lean principles. Clients served include Bristol-Myers Squibb, DuPont, Coca-Cola, and Siemens.
Invistics's top competitors include Generix Group, Syncron and DecisionPoint.
Invistics offers Sentri7 Drug Diversion, UpToDate, and CCH Axcess.
Invistics has 5 investors. Key investors include Wolters Kluwer, Atlanta Technology Angels, Intersouth Partners, H.I.G. Capital, and National Science Foundation.